Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/899866/000114036120028237/nc10017928x1_8k.htm
SEC Filings
ALXN Annual Reports
10-K Annual Report February 2021
10-K Annual Report February 2020
10-K Annual Report February 2019
10-K Annual Report February 2018
10-K Annual Report February 2017
10-K Annual Report February 2016
10-K Annual Report February 2015
10-K Annual Report February 2014
10-K Annual Report February 2013
10-K Annual Report February 2012
10-K Annual Report February 2021
10-K Annual Report February 2020
10-K Annual Report February 2019
10-K Annual Report February 2018
10-K Annual Report February 2017
10-K Annual Report February 2016
10-K Annual Report February 2015
10-K Annual Report February 2014
10-K Annual Report February 2013
10-K Annual Report February 2012
ALXN Quarterly Reports
10-Q Quarterly Report April 2021
10-Q Quarterly Report October 2020
10-Q Quarterly Report July 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report October 2019
10-Q Quarterly Report July 2019
10-Q Quarterly Report April 2019
10-Q Quarterly Report October 2018
10-Q Quarterly Report October 2018
10-Q Quarterly Report July 2018
10-Q Quarterly Report April 2021
10-Q Quarterly Report October 2020
10-Q Quarterly Report July 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report October 2019
10-Q Quarterly Report July 2019
10-Q Quarterly Report April 2019
10-Q Quarterly Report October 2018
10-Q Quarterly Report October 2018
10-Q Quarterly Report July 2018
ALXN Corporate News
Bylaw Change
Change in Assets
Change in Control
Ending Agreement
Event for Officers
Financial Exhibit
Listing Status
Security Holders Change July 2021
Earnings Release July 2021
Financial Exhibit
Other Events
Vote of Security Holders May 2021
Other Events May 2021
Earnings Release
Financial Exhibit April 2021
Financial Exhibit
Other Events March 2021
Event for Officers February 2021
Earnings Release
Financial Exhibit February 2021
Earnings Release
Financial Exhibit
Regulated Disclosure January 2021
Bylaw Change
Change in Assets
Change in Control
Ending Agreement
Event for Officers
Financial Exhibit
Listing Status
Security Holders Change
Change in Assets
Change in Control
Ending Agreement
Event for Officers
Financial Exhibit
Listing Status
Security Holders Change
July 2021
Earnings Release
July 2021
Financial Exhibit
Other Events
Vote of Security Holders
Other Events
Vote of Security Holders
May 2021
Other Events
May 2021
Earnings Release
Financial Exhibit
Financial Exhibit
April 2021
Financial Exhibit
Other Events
Other Events
March 2021
Event for Officers
February 2021
Earnings Release
Financial Exhibit
Financial Exhibit
February 2021
Earnings Release
Financial Exhibit
Regulated Disclosure
Financial Exhibit
Regulated Disclosure
January 2021
ALXN Merger Prospectus
425 Merger Prospectus July 2021
425 Merger Prospectus July 2021
425 Merger Prospectus July 2021
425 Merger Prospectus July 2021
425 Merger Prospectus June 2021
425 Merger Prospectus June 2021
425 Merger Prospectus June 2021
425 Merger Prospectus May 2021
425 Merger Prospectus May 2021
425 Merger Prospectus May 2021
425 Merger Prospectus July 2021
425 Merger Prospectus July 2021
425 Merger Prospectus July 2021
425 Merger Prospectus July 2021
425 Merger Prospectus June 2021
425 Merger Prospectus June 2021
425 Merger Prospectus June 2021
425 Merger Prospectus May 2021
425 Merger Prospectus May 2021
425 Merger Prospectus May 2021
Last10K.com | 8-K Material Event Mon Dec 14 2020
View differences made from one to another to evaluate Alexion Pharmaceuticals, Inc.'s financial trajectory
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Alexion Pharmaceuticals, Inc..
Assess how Alexion Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy
Alexion Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Material Contracts, Statements, Certifications & more
Alexion Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ALXNEvents:
CIK: 899866
Form Type: 8-K Corporate News
Accession Number: 0001140361-20-028237
Submitted to the SEC: Mon Dec 14 2020 9:05:44 AM EST
Accepted by the SEC: Mon Dec 14 2020
Period: Saturday, December 12, 2020
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/alxn/0001140361-20-028237.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...